Skip to navigation Skip to main content
Hasan Avcu, MD

Hasan Avcu, MD

H. Avcu, MD earned his Doctor of Medicine degree from Istanbul University Cerrahpasa School of Medicine in Istanbul, Turkey. He has been concentrating on medical communications, thought leader management, and healthcare compliance for the last decade. He has had numerous scientific interactions, implemented educational activities, and organized advisory board meetings with thought leaders in several therapeutic areas mainly focusing on rare diseases.

All articles by Hasan Avcu, MD

woman prepares an IV Drip
Features, KOL, Pompe Features

Late-Onset Pompe Disease in the Era of Enzyme Replacement Therapy

By
Publish Date

Pompe disease is a rare, multisystemic, autosomal recessive disease also known as glycogen storage disease type II. It is caused by the lack or deficiency of lysosomal acid-alpha-glucosidase (GAA), which leads to the accumulation of glycogen within lysosomes that manifests as a multisystem disorder. There was no specific treatment for Pompe disease until the first…

Alpha-1 Antitrypsin Deficiency & COVID-19
AATD Features, Features, KOL

Examining the Links Between SARS-CoV-2 and Alpha-1 Antitrypsin Deficiency

By
Publish Date

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can cause a variety of symptoms, and people with chronic lung disease including chronic obstructive pulmonary disease (COPD), chronic liver disease especially cirrhosis, diabetes, and cardiovascular disease are among those who are more prone to develop severe infection. We now know that severe SARS-CoV-2 infection is mainly…

  • Loading...

    Continuing Medical Education (CME/CE) Courses

    Show More

Next post in Features